...
首页> 外文期刊>Liver international : >Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease
【24h】

Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease

机译:慢性肾脏疾病与非酒精性脂肪肝病患者的死亡率较多,肾脏疾病独立相关

获取原文
获取原文并翻译 | 示例
           

摘要

Background & Aims Nonalcoholic fatty liver disease and chronic kidney disease share similar pathophysiologic features. Our aim was to assess the association between different stages of chronic kidney disease and mortality in patients with nonalcoholic fatty liver disease. Methods Third National Health and Nutrition Examination Survey-linked mortality files were utilized. Nonalcoholic fatty liver disease was diagnosed by hepatic ultrasound and chronic kidney disease was defined according to the Kidney Disease Improving Global outcomes guideline. Multivariable Cox proportional hazard model was used to assess the effect of chronic kidney disease on overall and cardiovascular mortality. Results Total cohort included 11 695 adult participants; mean age 43.3 years, 48.4% male, 76.4% white, 18.6% had nonalcoholic fatty liver disease and 9.3% had chronic kidney disease. 5.6% had diabetes, 21.3% had hypertension, 4.3% had cardiovascular disease. Compared to subjects without chronic kidney disease or nonalcoholic fatty liver disease, nonalcoholic fatty liver disease patients with chronic kidney disease were more likely to be older, had less income, and higher prevalence of comorbidities (all P < 0.001). Prevalence of chronic kidney disease among nonalcoholic fatty liver disease cohort was 11.31%. Compared to non-nonalcoholic fatty liver disease group, patients with nonalcoholic fatty liver disease had higher rates of stage 1, 2 and 3a chronic kidney disease, but similar rates for stage 3b, 4 and 5. Mortality rate was 18.5% in 17 years. Among nonalcoholic fatty liver disease cohort, the presence of chronic kidney disease stages 2-3a (HR = 2.31, 95% CI: 1.70-3.15) and stages 3b-5 (HR = 4.83, 95% CI: 2.40-9.71) were independently associated with increased overall mortality. Conclusions Among patients with nonalcoholic fatty liver disease, moderate to advanced stages of chronic kidney disease are associated with overall mortality. Identification of chronic kidney disease in nonalcoholic fatty liver disease has important prognostic implications.
机译:背景与目标非酒精性脂肪肝病和慢性肾病患有相似的病理物质特征。我们的目标是评估非酒精性脂肪肝病患者慢性肾病和死亡率之间的不同阶段之间的关联。方法采用第三条国家健康和营养考试调查综合死亡档案。通过肝超声和慢性肾病诊断非酒精性脂肪肝疾病根据肾脏疾病改善全球结果指南。多变量的Cox比例危险模型用于评估慢性肾病对整体和心血管死亡率的影响。结果总队列包括11 695名成人参与者;平均年龄43.3岁,男性48.4%,白色,18.6%的非酒精性脂肪肝病和9.3%患有慢性肾病。 5.6%患有糖尿病,21.3%具有高血压,4.3%有心血管疾病。与没有慢性肾病或非酒精性脂肪肝病的受试者相比,非酒精性脂肪肝病患者慢性肾病患者更容易较大,收入较少,并患有较高的合并症(所有P <0.001)。非酒精性脂肪肝疾病队列中慢性肾病的患病率为11.31%。与非酒精性脂肪肝病组相比,非酒精性脂肪肝病的患者具有较高的第1,2和3A和3A慢性肾病,但第3B阶段的速率相似,17岁的死亡率为18.5%。非酒精性脂肪肝病队列中,慢性肾病阶段的存在2-3A(HR = 2.31,95%CI:1.70-3.15)和阶段3B-5(HR = 4.83,95%CI:2.40-9.71)是独立的与总体死亡率增加有关。结论非酒精性脂肪肝病患者,中度至慢性肾病的先进阶段与总体死亡率相关。非酒精性脂肪肝病慢性肾病的鉴定具有重要的预后意义。

著录项

  • 来源
    《Liver international :》 |2019年第2期|共11页
  • 作者单位

    Inova Hlth Syst Betty &

    Guy Beatty Ctr Integrated Res Falls Church VA 22042 USA;

    Inova Hlth Syst Betty &

    Guy Beatty Ctr Integrated Res Falls Church VA 22042 USA;

    Inova Hlth Syst Betty &

    Guy Beatty Ctr Integrated Res Falls Church VA 22042 USA;

    Inova Fairfax Hosp Dept Med Ctr Liver Dis Falls Church VA USA;

    Inova Fairfax Hosp Dept Med Ctr Liver Dis Falls Church VA USA;

    Inova Hlth Syst Betty &

    Guy Beatty Ctr Integrated Res Falls Church VA 22042 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    hepatic; long-term; renal; survival;

    机译:肝脏;长期;肾脏;生存;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号